The Pharma Data

OCTOBER 30, 2020

To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Production 52

Production Antibody Manufacturing Trials 52

The Pharma Data

DECEMBER 17, 2020

To develop this novel medicine, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 52

Antibody Medicine Production Trials 52

The Pharma Data

OCTOBER 28, 2020

To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 40

Antibody Trials Production Clinical Trials 40

The Pharma Data

DECEMBER 5, 2020

Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories.

Antibody 40

Antibody Production Trials Medicine 40

The Pharma Data

JANUARY 24, 2021

Dr. Van Slyke is a biotechnology entrepreneur, scientist, and serial inventor. This press release contains “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information contained in this press release is expressly qualified by this cautionary statement.

Drugs 52

Drugs Containment Development Clinical Development 52

The Pharma Data

JANUARY 16, 2021

” He pledged to ramp up vaccination availability in pharmacies, build mobile clinics to get vaccines to underserved rural and urban communities and encourage states to expand vaccine eligibility to people 65 and older, The New York Times reported. As of Friday, over 31 million doses had been shipped to all 50 states and all U.S.

Vaccination 52

Vaccination Vaccine Nurses Packaging 52

The Pharma Data

JANUARY 12, 2021

Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories.

Antibody 52

Antibody Production Manufacturing Clinical Trials 52

The Pharma Data

NOVEMBER 20, 2020

PRF has funded and co-coordinated all Zokinvy-associated clinical trials for Progeria and Progeroid Laminopathies, conducted at Boston Children’s Hospital, and supports scientists who conduct Progeria research worldwide. NOTE REGARDING FORWARD-LOOKING STATEMENTS.

FDA Approval 52

FDA Approval Genetics Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 20, 2020

To develop this novel medicine, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 52

Antibody Production Clinical Trials Clinical Trials 52

Pfizer

SEPTEMBER 27, 2022

It’s this investment in innovation that enables our scientists to make dramatic strides in healthcare. In the current broken rebate system, insurers and pharmacy benefit managers negotiate substantial rebates with pharmaceutical companies to lower the price of medicines. 08.22.2022. See more Updates and Statements.

Medicine 40

Medicine Vaccination Vaccine Gene Therapy 40

The Pharma Data

NOVEMBER 21, 2020

To develop REGEN-COV2, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 40

Antibody Production Clinical Trials Clinical Trials 40

The Pharma Data

DECEMBER 29, 2020

To develop this novel medicine, Regeneron scientists evaluated thousands of fully-human antibodies produced by the company’s VelocImmune ® mice, which have been genetically modified to have a human immune system, as well as antibodies identified from humans who have recovered from COVID-19.

Antibody 52

Antibody Trials Production Clinical Trials 52

pharmaphorum

JANUARY 27, 2021

People tend to remember when things go wrong, and this casts doubt over procedures and leads to questions about whether we can really trust industry, scientists, and researchers. One ‘customer’ in the pharmacy says, “I didn’t realize everything needed to be tested.” I’m not an anti-vaxxer, but….”

Research 52

Research Clinical Trials Clinical Trials Vaccination 52

The Pharma Data

NOVEMBER 5, 2020

Founded and led for over 30 years by physician-scientists, Regeneron’s unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in Regeneron’s laboratories. About Regeneron Pharmaceuticals, Inc.

Sales 40

Sales Production Manufacturing Antibody 40

The Pharma Data

MAY 13, 2021

I’ll also show you why their top scientists are now saying that this breakthrough treatment could replace traditional medical approaches for a wide range of painful conditions… What this means is that you can now say goodbye to your daily aches and pains without harmful drugs or having to resort to painful surgery.

Production 52

Production Pharmacy Doctors Doctor 52

pharmaphorum

DECEMBER 15, 2022

One such example is the online pharmacy concept, like Pharmacy2U, with its 1.5 At this juncture, Professor Mike Bewick spoke, mentioning the methodology, subjects, and topline recommendations contained within the Report. In short, some people simply want to manage their own health. The UK as a powerhouse of research.

Life Science 97

Life Science Medicine Clinical Trials Clinical Trials 97

The Pharma Data

OCTOBER 14, 2020

“Decades of investment in our VelociSuite® rapid response technologies, the dedication of world-class scientists, and the courageous contributions of healthcare providers and patients, together with remarkable cooperation between leading international health organizations and governments, have led to this important moment.

FDA Approval 52

FDA Approval Antibody Production Trials 52

The Pharma Data

MAY 16, 2021

Contains a unique “living chemistry” that was poorly understood until recently…. Scientists have known about it for nearly 50 years, but it’s only recently…. An esteemed nutritional scientist Dr. Dr. Lejla Kreho working in the prestigious King’s College of London’s Biomedical Sciences department was able to prove….

Production 52

Production Containment Research Doctor 52

XTalks

SEPTEMBER 14, 2020

“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. WHO chief scientist, Soumya Swaminathan also expressed extreme skepticism of the new treatment’s benefits, stating that so far, there is little evidence to support the use of convalescent plasma for the treatment of COVID-19 infected patients. Drugs and Vaccines.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92

The Pharma Data

JANUARY 13, 2021

health officials have about containing the coronavirus in the coming months, U.S. If the vaccine can strongly protect people, as some scientists expect, only one shot would be required, making it far easier for local health departments and clinics to vaccinate residents. Other scientists agree.

Vaccination 52

Vaccination Vaccine Scientist Production 52